Bioter SA (VTRr)

Athens

Currency in EUR

0.21

0.00(0.00%)

Closed·30/05

Fair Value

Unlock Value

Day's Range

0.21

52 wk Range

0.21

VTRr Income Statement

Assess the Bioter income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the VTRr net worth.

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

0.25

0.5

1.26

0.39

Total Revenues Growth

aa.aa

+7.89%

+2.44%

+98.02%

+151.5%

-69%

Cost Of Revenues

aa.aa

1.18

0.27

0.55

0.3

0.23

Gross Profit

aa.aa

-0.94

-0.02

-0.05

0.96

0.16

Gross Profit Growth

aa.aa

+35.65%

+98.4%

-220%

+2,095.83%

-83.82%

Gross Profit Margin %

aa.aa

-380.08%

-5.95%

-9.62%

76.33%

39.85%

Other Operating Expenses, Total

aa.aa

0.51

1.42

2.43

12.95

2.03

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-27.34%	+180.99%	+71.04%	+433.66%	-84.33%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	0.51	1.42	2.43	12.95	2.03
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

aa.aa

-1.44

-1.43

-2.48

-11.99

-1.88

Operating Income Growth

aa.aa

+32.96%

+0.42%

-72.59%

-384.61%

+84.37%

EBIT Margin %

aa.aa

-585.37%

-569.05%

-495.99%

-955.7%

-482.01%

Net Interest Expenses

aa.aa

-8.24

-9.51

-10.18

-10.92

-0.03

Net Interest Expenses Growth

aa.aa

+16.75%

-15.47%

-7.02%

-7.32%

+99.74%

Interest Expense, Total

aa.aa

-8.59

-9.53

-10.18

-10.96

-0.03

Interest And Investment Income

aa.aa

0.35

0.01

0.04

Other Non Operating Expenses, Total

aa.aa

0.46

0.03

0.02

0.15

0.19

EBT, Excl. Unusual Items

aa.aa

-9.22

-10.92

-12.63

-22.77

-1.71

Gain (Loss) On Sale Of Assets

aa.aa

0.35

Other Unusual Items, Total

aa.aa

1.1

1.47

0.25

0.62

55.99

EBT, Incl. Unusual Items

aa.aa

-8.8

-9.45

-12.03

-22.15

54.28

EBT, Incl. Unusual Items Growth

aa.aa

-226.95%

-7.35%

-27.32%

-84.08%

+345.09%

EBT, Incl. Unusual Items Margin

aa.aa

-3,578.46%

-3,750%

-2,411.22%

-1,764.78%

13,954.24%

Income Tax Expense

aa.aa

0.02

0.21

-0.26

-1.02

-0.16

Net Income to Company

aa.aa

-8.82

-9.66

-11.78

-21.13

54.44

Minority Interest

aa.aa

0.01

-0.01

0.1

-0.13

0.06

Net Income

aa.aa

-8.81

-9.68

-11.68

-21.26

54.49

Net Income Growth

aa.aa

-245.51%

-9.85%

-20.71%

-81.99%

+356.34%

Net Income Margin %

aa.aa

-3,580.89%

-3,840.08%

-2,340.88%

-1,693.86%

14,008.48%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-8.81

-9.68

-11.68

-21.26

54.49

Basic EPS - Continuing Operations

aa.aa

-0.53

-0.58

-0.7

-1.27

3.26

Basic EPS - Continuing Operations Growth

aa.aa

-245.51%

-9.85%

-20.71%

-81.99%

+356.34%

Diluted EPS - Continuing Operations

aa.aa

-0.53

-0.58

-0.7

-1.27

3.26

Diluted EPS - Continuing Operations Growth

aa.aa

-245.51%

-9.85%

-20.71%

-81.99%

+356.34%

Basic Weighted Average Shares Outstanding

aa.aa

16.73

Diluted Weighted Average Shares Outstanding

aa.aa

16.73

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

-1.32

-1.34

-2.38

-11.9

-1.77

EBITDA Growth

aa.aa

+35.15%

-1.51%

-77.63%

-399.58%

+85.11%

EBITDA Margin %

aa.aa

-536.99%

-532.14%

-477.35%

-948.21%

-455.53%

EBIT

aa.aa

-1.44

-1.43

-2.48

-11.99

-1.88

* In Millions of EUR (except for per share items)

FAQ

What was Bioter’s revenue at year end?

At the end of the last reported fiscal year, Bioter (VTRr) recorded total revenue of 0.39 million EUR.

What was Bioter’s net income for the year?

For the full year, Bioter reported net income of 54.49 million EUR.

What was Bioter’s gross profit for the year?

Gross profit for the year was reported at 0.16 million EUR.

What was Bioter’s annual operating income?

For the full year, Bioter (VTRr) reported operating income of -1.88 million EUR.

S&P/TSX

36,620.23

+254.81

+0.70%

S&P/TSX 60

2,144.95

+13.44

+0.63%

US 30

53,261.40

+499.1

+0.95%

US 500

7,671.10

+29.4

+0.39%

S&P 500 VIX

15.13

-0.88

-5.50%

DAX

26,136.56

+153.52

+0.59%

Dollar Index

98.77

-0.050

-0.05%

Market Movers

Name	Last	Chg. %	Vol.
Enbridge	69.54	-1.32%	11.25M
RBC	282.37	-0.34%	2.53M
Canadian Natural	70.81	+0.53%	9.53M
Agnico Eagle Mines	297.82	+1.95%	1.92M
Toronto Dominion Bank	161.24	-0.11%	2.78M
Bank of Nova Scotia	120.57	+1.01%	3.65M
Suncor Energy	94.25	+0.46%	4.06M

Name	Last	Chg. %	Vol.
Lanebury Growth Capital	0.15	+200.00%	1.00K
Pharmadrug	0.01	+200.00%	2.00K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
Lithos Energy	0.21	+110.00%	500.00
55 North Mining	0.38	+108.11%	49.59K
Pharmadrug	0.0100	+100.00%	2.00K
Iemr Resources	0.0100	+100.00%	4.00K

Name	Last	Chg. %	Vol.
Psyched Wellness	0.01	-100.00%	8.28K
Patriot Gold	0.01	-87.50%	1.00K
Playground Ventures	0.010	-50.00%	1.00K
Molecule Holdings	0.005	-50.00%	20.11K
Albert Labs International	0.005	-50.00%	1.00K
Nobel29 Resources	0.02	-50.00%	2.09K
James Bay Resources Ltd	0.010	-50.00%	104.45K

Trending Stocks

Name	Last	Chg. %	Vol.
Canadian Natural	70.81	+0.53%	9.53M
Celestica Inc.	407.67	-2.18%	278.59K
Hut 8	111.300	-9.14%	850.23K
TELUS	13.61	-1.45%	6.09M
Toronto Dominion Bank	161.24	-0.11%	2.78M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaa Aaaaaaaaaaa Aa	33.97	+56.59%	53.19
Aaaaa A A	121.49	+50.43%	182.76
Aaaaaaaaa Aaa	103.14	+44.86%	149.41
Aaaaaaa Aaaaaa	30.09	+43.48%	43.17
A Aa Aaaaaaa Aaaaaa	21.34	+42.11%	30.33
Aaaaa Aaaaa Aaaaa	17.24	+41.02%	24.31
Aaaaaaaa	7.61	+38.32%	10.53

Name	Last	Upside	Fair Value
Aaa Aaaaaaaaaaa Aa	33.97	+56.59%	53.19
Aaaaa A A	121.49	+50.43%	182.76
Aaaaaaaaa Aaa	103.14	+44.86%	149.41
Aaaaaaa Aaaaaa	30.09	+43.48%	43.17
A Aa Aaaaaaa Aaaaaa	21.34	+42.11%	30.33
Aaaaa Aaaaa Aaaaa	17.24	+41.02%	24.31
Aaaaaaaa	7.61	+38.32%	10.53

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Bioter SA (VTRr)

VTRr Income Statement

FAQ

What was Bioter’s revenue at year end?

What was Bioter’s net income for the year?

What was Bioter’s gross profit for the year?

What was Bioter’s annual operating income?

Trending Stocks